| Autor: |
Anwar Jammah, Nagwa Roushdy, Mohamed Gamil, Nidal Abu Diab, Naglaa Abdelmonaem, Saher Safarini, Mohamed Gadallah, Nedal Abu Zaid, Yahya Shihadeh, Mohamed Saeed, Jamaa Sadik, Yasser Akil |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Endocrine and Metabolic Science, Vol 15, Iss , Pp 100164- (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2666-3961 |
| DOI: |
10.1016/j.endmts.2024.100164 |
| Popis: |
Introduction: The prevalence of type 2 diabetes mellitus (T2DM) has increased in Saudi Arabia over recent decades, with current estimates showing that 19% of adults have T2DM. There is a need to confirm the clinical outcomes and safety of iGlarLixi in the routine clinical practice setting. Methods: A multicenter retrospective non-comparative study was conducted on 224 people with T2DM on Oral anti-diabetics (OADs) or in combination with basal insulin who initiated treatment with iGlarLixi in Saudi Arabia. Data of at least 180 days (± 30 days) before and after initiating iGlarLixi were retrieved. Results: Mean HbA1c significantly decreased after iGlarLixi start, with a mean reduction of 1.6% at six months. The mean reduction in the FPG was −38.8 (95% CI -46.5 to −31.1, p |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
